{"resourceType":"Bundle","type":"searchset","entry":[{"resource":{"resourceType":"Parameters","id":"ImmDS-2013-0495","parameter":[{"name":"assessentDate","valueDate":"2020-06-29"},{"name":"patient","resource":{"resourceType":"Patient","id":"2013-0495","name":[{"text":"#2 with interval of 5 years of #1\nEvaluation_Test_Type: Interval: At Recommended\nGeneral_Description: This test case describes when dose #2 of a Mening vaccine is administered 5 years after dose #1 (age 13), that the dose in considered valid. The series is complete."}],"gender":"female","birthDate":"2002-06-29"}},{"name":"immunization","resource":{"resourceType":"Immunization","id":"2013-0495-dose1","status":"completed","vaccineCode":{"coding":[{"system":"http://hl7.org/fhir/sid/cvx","code":"114","display":"MENACTRA"},{"system":"http://hl7.org/fhir/v2/0227","code":"PMC","display":"MENACTRA"}]},"patient":{"reference":"Patient/2013-0495"},"occurrenceDateTime":"2015-06-29T00:00:00.000"}},{"name":"immunization","resource":{"resourceType":"Immunization","id":"2013-0495-dose2","status":"completed","vaccineCode":{"coding":[{"system":"http://hl7.org/fhir/sid/cvx","code":"114","display":"MENACTRA"},{"system":"http://hl7.org/fhir/v2/0227","code":"PMC","display":"MENACTRA"}]},"patient":{"reference":"Patient/2013-0495"},"occurrenceDateTime":"2020-06-29T00:00:00.000"}}]},"request":{"method":"PUT","url":"Parameters"}}]}